Benjamin J. Hindson, See Remarks at 10x Genomics, Inc. (TXG), sold 78,432 shares at $145.43 ($11.5M) on 2022-01-03, disclosed to the SEC on 2022-01-05.
Open-market sale of $11.5M TXG by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $144.56 | 2,300 | $332K | 2.9% |
| 2 | $145.43 | 16,464 | $2.4M | 20.9% |
| 3 | $145.43 | 16,464 | $2.4M | 20.9% |
| 4 | $146.29 | 17,396 | $2.5M | 22.2% |
| 5 | $146.29 | 17,396 | $2.5M | 22.2% |
| 6 | $147.34 | 2,906 |
| $428K |
| 3.7% |
| 7 | $147.34 | 2,906 | $428K | 3.7% |
| 8 | $148.44 | 2,000 | $297K | 2.6% |
| 9 | $149.24 | 600 | $90K | 0.8% |
| Total | $146.03 avg | 78,432 | $11.5M | 100% |
| Filing → |
| TXG | SELL | 2026-02-25 | $145K | — | Filing → |
| TXG | SELL | 2025-11-25 | $157K | — | Filing → |
| TXG | SELL | 2025-08-26 | $206K | — | Filing → |